Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    dermatology

    Cutaneous small-vessel vasculitis

    Also known as: CSVV, Cutaneous leukocytoclastic vasculitis, Cutaneous small vessel vasculitis, Skin-limited small-vessel vasculitis

    Cutaneous small-vessel vasculitis (CSVV) is an inflammatory condition of the small dermal vessels, typically presenting with palpable purpura and occasionally painful ulceration. Assessment must identify potential drug or disease triggers and differentiate isolated cutaneous disease from systemic vasculitis and thrombotic mimics. Diagnostic evaluation may include skin biopsy and investigation for multi-organ involvement. the cited evidence comprises two treatment case reports, an immunopathogenesis review, and a retrospective study of livedoid vasculopathy (a distinct thrombo-occlusive disorder); none establishes acupuncture or herbal efficacy for CSVV, and reported targeted therapies require specialist judgement. Traditional Chinese Medicine may provide individualised, symptom-oriented adjunctive care following medical assessment, provided it does not delay investigation, wound management, or prescribed treatment. The documented patterns represent interpretive frameworks rather than validated clinical subtypes.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Maintain a dated photographic log of cutaneous lesions and document fluctuations in pain or the emergence of new ulcerations to facilitate clinical monitoring.
    • •Disclose all recent pharmacological agents, supplements, or preceding infections to the attending physician; do not cease essential medications without clinical consultation.
    • •Protect friable skin from mechanical friction or trauma and adhere strictly to prescribed wound dressing and skin-care protocols.
    • •Balance periods of rest with gentle mobilisation and limb elevation; consult a medical professional prior to the application of compression hosiery.

    Cautions & Contraindications

    See sources
    • •Do not needle through purpura, ulcers, necrotic tissue or suspected infection, and avoid local bleeding techniques. Painful ulceration is documented in CSVV; this procedural precaution is not tested in the supplied case report.[]
    • •Do not use acupuncture or herbs instead of assessment for systemic disease, and do not independently alter corticosteroids, immunosuppressants or targeted therapies. The supplied review supports specialist-directed disease management, not TCM substitution.[]
    • •When anticoagulants or antiplatelet medicines are used, assess bleeding risk before needling or blood-moving herbal formulas and obtain prescribing-team input. Their use is described in the livedoid vasculopathy cohort, which does not provide direct evidence about acupuncture or herb interactions in CSVV.[]

    When to reassess or seek care again

    See sources

    Medical review takes priority during active disease. If stable and cleared for adjunctive care, review within 7–14 days using new-lesion count, standardised photographs, pain score from 0–10, sleep, walking tolerance and clinician-measured ulcer dimensions where relevant. Stop adjunctive treatment and arrange earlier medical review for increasing lesions, impaired healing, adverse effects or new systemic symptoms. If no meaningful symptom benefit after 2–4 weeks, discontinue and reconsider the plan with the treating team; skin improvement does not exclude organ involvement.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Frontiers in medicine · 2026
    2. Clinical, cosmetic and investigational dermatology · 2023
    3. Clinical, cosmetic and investigational dermatology · 2025
    4. Frontiers in cardiovascular medicine · 2021

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.